Literature DB >> 7747698

Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials.

C P Cannon1, B Thompson, C H McCabe, H S Mueller, J M Kirshenbaum, S Herson, J B Nasmith, B R Chaitman, E Braunwald.   

Abstract

Among patients with acute ischemic syndromes, patients with non-Q-wave acute myocardial infarction (AMI) are known to be at higher risk for death, reinfarction, and other morbidity than those with unstable angina. The aim of this study was to develop a clinically useful prediction rule to assist in distinguishing, at the time of presentation, patients with non-Q-wave AMI from those with unstable angina. The TIMI IIIB trial enrolled 1,473 patients presenting with ischemic pain at rest within 24 hours who had either electrocardiographic changes or documented coronary artery disease. Non-Q-wave AMI on presentation was documented by elevation of creatine kinase-MB in 33% of patients. Fifty clinical and electrocardiographic variables were compared between the patients with non-Q-wave AMI and unstable angina. After performing logistic regression, 4 baseline characteristics independently predicted non-Q-wave myocardial AMI: the absence of prior coronary angioplasty (odds ratio [OR] = 3.3, p < 0.001), duration of pain > or = 60 minutes (OR = 2.9, p < 0.001), ST-segment deviation on the qualifying electrocardiogram (OR = 2.0, p < 0.001), and recent-onset angina (OR = 1.7, p = 0.002). Using these 4 characteristics, a prediction rule for non-Q-wave AMI was developed. For the entire cohort of patients in TIMI III, the percentages of patients with non-Q-wave AMI when 0, 1, 2, 3, and 4 risk factors were present were 7.0%, 19.6%, 24.4%, 49.9%, and 70.6%, respectively (p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7747698     DOI: 10.1016/s0002-9149(99)80707-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council.

Authors:  F W Verheugt; R C Becker; M E Bertrand; C Bode; J H Chesebro; J G Cleland; R Conti; W S Hillis; W Klein; A Maseri; A G Turpie; L Wallentin; D D Waters
Journal:  Clin Cardiol       Date:  1999-09       Impact factor: 2.882

2.  Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers.

Authors:  S Kennon; C P Price; P G Mills; P K MacCallum; J Cooper; J Hooper; H Clarke; A D Timmis
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 3.  Management strategies for a better outcome in unstable coronary artery disease.

Authors:  R W Campbell; L Wallentin; F W Verheugt; A G Turpie; A Maseri; W Klein; J G Cleland; C Bode; R Becker; J Anderson; M E Bertrand; C R Conti
Journal:  Clin Cardiol       Date:  1998-05       Impact factor: 2.882

4.  Optimizing the Treatment of Unstable Angina.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

5.  A cardiac troponin I study in a minimally invasive myocardial infarction canine model.

Authors:  Reyaj Mikrani; Cuilan Liang; Muhammad Naveed; Asghar Ali Kamboh; Muhammad Abbas; Birendra Chaurasiya; Li Xue; Zhou Xiaohui
Journal:  J Appl Biomed       Date:  2018-11-23       Impact factor: 1.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.